MedTrace Logo

Pertussis Vaccination in Pregnant Women

NCT03909126 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 946

Last updated 2021-09-24

No results posted yet for this study

Summary

Brief Summary: The study compares four models of pertussis vaccination dispensation to pregnant women on the vaccine coverage obtained. In addition, the cost of the different models of vaccination will be evaluated.

Conditions

  • Pertussis

Interventions

BIOLOGICAL

Boostrix administered during gestational diabetes screening

Boostrix administered during gestational diabetes screening

BIOLOGICAL

Boostrix administered in high volume obstetric clinic

Boostrix administered in high volume obstetric clinic

Sponsors & Collaborators

  • Ministere de la Sante et des Services Sociaux

    collaborator OTHER

  • St. Justine's Hospital

    lead OTHER

Principal Investigators

  • Caroline Quach, MD · St. Justine's Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2021-05-30
Completion
2021-05-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03909126 on ClinicalTrials.gov